4577.T | Daito Pharmaceutical Co.,Ltd. Annual & Quarterly

Annual Balance Sheets

(In JPY)

Breakdown	2024	2023	2022	2021	2020	2019
Total Assets	77.7 Billion	70.55 Billion	64.93 Billion	57.73 Billion	54.24 Billion	46.74 Billion
Total Current Assets	41.46 Billion	40.66 Billion	37.9 Billion	32.42 Billion	30.85 Billion	24.36 Billion
Cash And Short Term Investments	2.72 Billion	3.6 Billion	4.38 Billion	3.37 Billion	3.08 Billion	1.81 Billion
Cash and Cash Equivalents	2.72 Billion	3.6 Billion	4.38 Billion	3.37 Billion	3.08 Billion	1.81 Billion
Short Term Investments	-	-205 Million	-206 Million	-294.2 Million	-249.46 Million	-240.02 Million
Net Receivables	16.73 Billion	10.67 Billion	10.58 Billion	8.38 Billion	9.06 Billion	9.39 Billion
Inventory	20.89 Billion	18.23 Billion	16.82 Billion	15.75 Billion	12.13 Billion	10.05 Billion
Other Current Assets	1.11 Billion	8.14 Billion	6.12 Billion	4.92 Billion	6.57 Billion	3.08 Billion
Total Non-Current Assets	36.24 Billion	29.88 Billion	27.02 Billion	25.3 Billion	23.39 Billion	22.38 Billion
Net PPE	31.97 Billion	25.83 Billion	23.11 Billion	21.37 Billion	19.39 Billion	18.73 Billion
Good Will And Intangible Assets	490 Million	377 Million	386 Million	332.68 Million	299.35 Million	306.5 Million
Good Will	-	-	-	-	-	-
Intangible Assets	490 Million	377 Million	386 Million	332.68 Million	299.35 Million	306.5 Million
Long-Term Investments	3.18 Billion	3.16 Billion	2.95 Billion	3.09 Billion	3.39 Billion	3.02 Billion
Tax Assets	320 Million	504 Million	570 Million	508.01 Million	302.28 Million	329.79 Million
Other Non Current Assets	278 Million	-	-1 Million	723 Thousand	332 Thousand	165 Thousand
Other Assets	-	2 Million	1 Million	2000.00	2000.00	3000.00
Total Liabilities	25.43 Billion	19.58 Billion	17.26 Billion	15.82 Billion	17.38 Billion	15.39 Billion
Total Current Liabilities	18.5 Billion	15.42 Billion	14.06 Billion	12.85 Billion	15.05 Billion	11.61 Billion
Account Payables	8.69 Billion	4.43 Billion	4.49 Billion	4.35 Billion	4.33 Billion	4.08 Billion
Tax Payables	195 Million	559 Million	1.4 Billion	1.09 Billion	1.3 Billion	351.94 Million
Short Term Debt	2.37 Billion	1.51 Billion	1.2 Billion	1.37 Billion	1.78 Billion	2.31 Billion
Deferred Revenue	195 Million	5.37 Billion	4.48 Billion	3.72 Billion	4.53 Billion	2.45 Billion
Other Current Liabilities	7.23 Billion	4.1 Billion	3.88 Billion	3.39 Billion	4.41 Billion	2.76 Billion
Total Non Current Liabilities	6.93 Billion	4.15 Billion	3.19 Billion	2.96 Billion	2.32 Billion	3.78 Billion
Long-Term Debt	4.66 Billion	3.44 Billion	2.24 Billion	2.01 Billion	1.58 Billion	3.09 Billion
Deferred Revenue Non Current	1.67 Billion	507 Million	755 Million	764.34 Million	568.22 Million	506.14 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	557 Million	170 Million	165 Million	151 Million	148.8 Million	146.75 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	52.26 Billion	50.97 Billion	47.67 Billion	41.91 Billion	36.86 Billion	31.34 Billion
Stock Holders Equity	52.06 Billion	50.67 Billion	47.3 Billion	41.61 Billion	36.5 Billion	30.94 Billion
Common Stock	7.18 Billion	7.18 Billion	7.03 Billion	6.27 Billion	5.37 Billion	4.36 Billion
Retained Earnings	37.08 Billion	35 Billion	32.33 Billion	28.33 Billion	24.74 Billion	21.3 Billion
Accumulated other comprehensive income	1.71 Billion	1.53 Billion	1.03 Billion	872.38 Million	1.15 Billion	1.03 Billion
Common Stock Equity	52.06 Billion	50.67 Billion	47.3 Billion	41.61 Billion	36.5 Billion	30.94 Billion
Capital Lease Obligation	1.67 Billion	92 Million	-	1.5 Million	4.49 Million	9.13 Million
Total Investments	3.18 Billion	2.96 Billion	2.75 Billion	2.8 Billion	3.14 Billion	2.77 Billion
Total Debt	8.71 Billion	4.95 Billion	3.44 Billion	3.39 Billion	3.36 Billion	5.41 Billion
Net Debt	5.99 Billion	1.35 Billion	-934 Million	21.08 Million	280.89 Million	3.59 Billion

Breakdown	2024 Q1	2023 Q4	2023 FY	2023 Q3	2023 Q2	2023 Q1
Total Assets	81.92 Billion	77.7 Billion	77.7 Billion	77.35 Billion	74.99 Billion	71.51 Billion
Total Current Assets	45.84 Billion	41.46 Billion	41.46 Billion	42.89 Billion	44.85 Billion	41.16 Billion
Cash And Short Term Investments	4.69 Billion	2.72 Billion	2.72 Billion	3.78 Billion	4.58 Billion	4 Billion
Cash and Cash Equivalents	4.69 Billion	2.72 Billion	2.72 Billion	3.78 Billion	4.58 Billion	4 Billion
Short Term Investments	-	-	-	-	-	-
Net Receivables	18.61 Billion	16.73 Billion	16.73 Billion	16.46 Billion	12.99 Billion	11.13 Billion
Inventory	21.59 Billion	20.89 Billion	20.89 Billion	21.31 Billion	19.94 Billion	19.01 Billion
Other Current Assets	941 Million	1.11 Billion	1.11 Billion	1.33 Billion	7.32 Billion	7 Billion
Total Non-Current Assets	36.08 Billion	36.24 Billion	36.24 Billion	34.45 Billion	30.13 Billion	30.35 Billion
Net PPE	31.42 Billion	31.97 Billion	31.97 Billion	30.4 Billion	26.02 Billion	26.36 Billion
Good Will And Intangible Assets	492 Million	490 Million	490 Million	386 Million	365 Million	376 Million
Good Will	-	-	-	-	-	-
Intangible Assets	492 Million	490 Million	490 Million	386 Million	365 Million	376 Million
Long-Term Investments	2.3 Billion	3.18 Billion	3.18 Billion	3.02 Billion	3.06 Billion	3.12 Billion
Tax Assets	-	320 Million	320 Million	2 Million	-3.06 Billion	-3.12 Billion
Other Non Current Assets	1.86 Billion	278 Million	278 Million	639 Million	3.74 Billion	3.61 Billion
Other Assets	-	-	-	-	1 Million	-
Total Liabilities	29.84 Billion	25.43 Billion	25.43 Billion	25.3 Billion	22.86 Billion	20.18 Billion
Total Current Liabilities	18.79 Billion	18.5 Billion	18.5 Billion	18.69 Billion	16.41 Billion	16.37 Billion
Account Payables	10.99 Billion	8.69 Billion	8.69 Billion	9.65 Billion	6.49 Billion	5.52 Billion
Tax Payables	-	195 Million	195 Million	235 Million	846 Million	250 Million
Short Term Debt	3.29 Billion	2.37 Billion	2.37 Billion	2.11 Billion	2.13 Billion	1.37 Billion
Deferred Revenue	475 Million	195 Million	195 Million	235 Million	939 Million	609 Million
Other Current Liabilities	4.02 Billion	7.23 Billion	7.23 Billion	6.69 Billion	6.84 Billion	8.87 Billion
Total Non Current Liabilities	11.05 Billion	6.93 Billion	6.93 Billion	6.61 Billion	6.45 Billion	3.8 Billion
Long-Term Debt	8.84 Billion	4.66 Billion	4.66 Billion	5.19 Billion	5.71 Billion	3.04 Billion
Deferred Revenue Non Current	-	1.67 Billion	1.67 Billion	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	2.21 Billion	557 Million	557 Million	1.41 Billion	740 Million	764 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	52.08 Billion	52.26 Billion	52.26 Billion	52.04 Billion	52.12 Billion	51.33 Billion
Stock Holders Equity	52 Billion	52.06 Billion	52.06 Billion	51.8 Billion	51.86 Billion	51.04 Billion
Common Stock	7.18 Billion	7.18 Billion	7.18 Billion	7.18 Billion	7.18 Billion	7.18 Billion
Retained Earnings	36.38 Billion	37.08 Billion	37.08 Billion	36.13 Billion	36.12 Billion	35.25 Billion
Accumulated other comprehensive income	1.48 Billion	1.71 Billion	1.71 Billion	1.53 Billion	1.6 Billion	1.65 Billion
Common Stock Equity	52 Billion	52.06 Billion	52.06 Billion	51.8 Billion	51.86 Billion	51.04 Billion
Capital Lease Obligation	-	1.67 Billion	1.67 Billion	-	-	-
Total Investments	2.3 Billion	3.18 Billion	3.18 Billion	3.02 Billion	3.06 Billion	3.12 Billion
Total Debt	12.14 Billion	8.71 Billion	8.71 Billion	7.3 Billion	7.84 Billion	4.42 Billion
Net Debt	7.45 Billion	5.99 Billion	5.99 Billion	3.51 Billion	3.26 Billion	420 Million

Balance Sheet Charts

Iwaki Co., Ltd.

6237

Full Analysis

Annual Balance Sheets
Profithol, S.A.

SPH

Full Analysis

Annual Balance Sheets
Navin Fluorine International Limited

NAVINFLUOR

Full Analysis

Annual Balance Sheets
Deutsche Börse AG

DBOEY

Full Analysis

Annual Balance Sheets
Zoned Properties, Inc.

ZDPY

Full Analysis

Annual Balance Sheets
Nova System Co.,Ltd.

5257

Full Analysis

Annual Balance Sheets

Global Stocks Search

Daito Pharmaceutical Co.,Ltd. (4577.T)

Annual Balance Sheets

Balance Sheet Charts

Iwaki Co., Ltd.

Profithol, S.A.

Navin Fluorine International Limited

Deutsche Börse AG

Zoned Properties, Inc.

Nova System Co.,Ltd.